DONATE

12th Annual Conference of Biomedical Research Technology Platforms

The Spanish Platform for Nanomedicine (NanoMedSpain) coordinated by Josep Samitier, director of IBEC, has participated once again in the Annual Conference of Technological Platforms of Biomedical Research that took place in Madrid during the days 5 an 6 of March.

This yearly conference, organised by the four national platforms Farmaindustria, Asebio, NanomedSpain and FENIN -Innovative medicines, nanomedicine, sanitary technology and biotechnological markets- where the main issue was how to boost biomedical research hubs in Spain. During the morning of the 5th of March, the directors of each platform presented a summary of their activity during 2018, after which their invited speakers gave talks. This year, NanomedSpain has invited Per Matsson, president of EIT Health Scandinavia and CTO at Thermo Fisher Scientific Immunodiagnostics whose speech was entitled “Innovation in health: from biomarker discovery to implementation”.

Postdoc position at the Smart Nano-Bio-Devices Research Group – ERC funded project

Application Deadline: 28/03/2019
Ref: PD-SS
The nanodevices group at the Institute for Bioengineering of Catalonia (IBEC) is looking for one Postdoctoral researcher to participate in the ERC-funded project “Lab-in-a-patch for PKU self-assessment”. The main scientific aim of the project is the development of low cost, integrated, and portable sensors or on-chip microfluidic sensors for the non-invasive detection of disease-related bio-analytes (proteins, amino acids, electrolytes, etc.) and help monitor the evolution of pathological conditions.

IBEC Seminar: Paul Wright

Nanosafety research addressing public health concerns about metal oxide nanoparticles Paul Wright, Head of RMIT Nanosafety Research Group – RMIT University Paul Wright is Australia’s foremost expert in nanotoxicology and … Read more

IBEC Seminar: Paul Wright

Nanosafety research addressing public health concerns about metal oxide nanoparticles Paul Wright, Head of RMIT Nanosafety Research Group – RMIT University Paul Wright is Australia’s foremost expert in nanotoxicology and … Read more

IBEC Seminar: Paul Wright

Nanosafety research addressing public health concerns about metal oxide nanoparticles Paul Wright, Head of RMIT Nanosafety Research Group – RMIT University Paul Wright is Australia’s foremost expert in nanotoxicology and … Read more

IBEC Seminar: Paul Wright

Nanosafety research addressing public health concerns about metal oxide nanoparticles Paul Wright, Head of RMIT Nanosafety Research Group – RMIT University Paul Wright is Australia’s foremost expert in nanotoxicology and … Read more

A new technique allows researchers to focus the action of drugs via infrared light

A scientific team led by IBEC and UAB manages to efficiently activate molecules located inside cell tissues using two-photon excitation of with infrared light lasers. The results of the study has been published in Nature Communications.

Having absolute control of the activity of a molecule in an organism. Deciding when, where and how a drug is activated. These are some of the goals expected to be reached with the so-called photoswitchable molecules, compounds that, in the presence of certain light waves, change their properties. Today, thanks to the results of a study led by the Institute for Bioengineering of Catalonia (IBEC) together with the Universitat Autònoma de Barcelona (UAB), the scientific community is one step closer to achieving this objective.

Tècnic de Laboratori (Ref. TL-IO)

Application Deadline: 15/03/2019
Ref: TL-IO

L’Institut de Bioenginyeria de Catalunya (IBEC) requereix incorporar un/-a tècnic/-a de laboratori per a les MicroFab & Microscopy Facilities , part de la unitat de Core Facilities de l’IBEC, que te la funció de proporcionar serveis i suport diaris als usuaris de sala blanca on es fabriquen i caracteritzen microdispositius i estructures per a aplicacions biomèdiques, i suport un servei de caracterització per microscòpia SEM i confocal.

Urea-powered nanomotors a promising therapy for bladder cancer

IBEC’s Smart Nano-Bio-Devices group have published a paper describing nanomotors that can attack 3D bladder cancer spheroids in vitro.

The nanomotors carry anti-FGFR3 on their outer surface, an antibody that not only enables cancerous cells to be specifically targeted, but also inhibits the fibroblast growth factor signaling pathway, suppressing tumor growth. Crucially, the fuel that gives the nanomotors the capability of autonomous motion is urea, which is present at high concentrations in the bladder – making these particular nanomotors a promising avenue for this particular cancer.